AcelRx

FDA rejection blocks another AcelRx drug from US market
FDA rejection blocks another AcelRx drug from US market
Biopharma Dive
FDA
AcelRx
Dsuvia
Flag link:
In a new setback, FDA kicks back AcelRx’s application for pain med — shares tank again
In a new setback, FDA kicks back AcelRx’s application for pain med — shares tank again
Endpoints
FDA
AcelRx
Dsuvia
ARX-04
painkillers
Flag link:
Why AcelRx Pharmaceuticals Inc Jumped Higher Today
Why AcelRx Pharmaceuticals Inc Jumped Higher Today
Motley Fool
AcelRx
painkillers
Dsuvia
FDA
Flag link:
AcelRx’s pain relief drug-device combo succeeds in late-stage trial
AcelRx’s pain relief drug-device combo succeeds in late-stage trial
Drug Delivery Business News
AcelRx
Zalviso
devices
drug-device combos
Flag link:
5 Biotech Stocks With Major Catalysts in July
5 Biotech Stocks With Major Catalysts in July
Motley Fool
biotech
AcelRx
Zalviso
Alnylam
Patisiran
Dynavax
HEPLISAV-B
GSK
Benlysta
Puma Biotechnology
neratinib
Flag link:
AcelRx's opioid painkiller succeeds in key study
AcelRx's opioid painkiller succeeds in key study
Yahoo/Reuters
AcelRx
opioids
painkillers
clinical trials
Flag link:
AcelRx Pharma's pain drug succeeds in late-stage study
AcelRx Pharma's pain drug succeeds in late-stage study
Yahoo/Reuters
AcelRx
painkillers
ARX-04
Flag link:
7 Biotech Stocks Moving Off The UBS Healthcare Conference
7 Biotech Stocks Moving Off The UBS Healthcare Conference
Yahoo/Benzinga
biotech
UBS
AcelRx
Affirmed NV
Atara
Cerulean Pharma
Endo International
Esperion Therapeutics
Immune Design
Flag link:
FDA rejects AcelRx's request for meeting on pain drug device
FDA rejects AcelRx's request for meeting on pain drug device
Yahoo/Reuters
FDA
devices
AcelRx
Zalviso
Flag link:
A New Drug In The Works, A New CEO, And A New Delay For AcelRx Pharmaceuticals
A New Drug In The Works, A New CEO, And A New Delay For AcelRx Pharmaceuticals
Seeking Alpha
AcelRx
Zalviso
Flag link:
AcelRx hammered (again) after FDA demands a new Zalviso study after all
AcelRx hammered (again) after FDA demands a new Zalviso study after all
Fierce Biotech
AcelRx
FDA
Zalviso
Dune Medical Devices
Flag link:
AcelRx Pharmaceuticals (ACRX) Stock Rises After Third-Quarter Earnings Report
AcelRx Pharmaceuticals (ACRX) Stock Rises After Third-Quarter Earnings Report
TheStreet.com
AcelRx
earnings
Flag link:
AcelRx shares plunge after FDA rejects its pain drug/device system
AcelRx shares plunge after FDA rejects its pain drug/device system
Fierce Biotech
FDA
devices
AcelRx
painkillers
Zalviso
Flag link:
2nd Half Of 2014 Biotechnology Catalysts: Part 1
2nd Half Of 2014 Biotechnology Catalysts: Part 1
Seeking Alpha
AcelRx
Anacor
BioDelivery Sciences
Eagle Pharmaceuticals
MannKind
Navidea Biopharmaceuticals
Orexigen
Omeros
EnteroMedics
Progenics
Trimel Pharmaceuticals
Flag link:
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
The Best- And Worst-Performing Biotech Stocks July 5 To July 12
Forbes
Vivus
Trius Therapeutics
Prosensa
Pharmacyclics
NxStage Medical
Natus Medical
MiMedx
Merrimack Pharmaceuticals
Intuitive Surgical
InterMune
GTx
Fluidigm
Epizyme
Celldex
Astex
Analogic
Amarin
Alnylam
Alexion
AcelRx
Flag link:
This Week in Biotech
This Week in Biotech
Motley Fool
AcelRx
Peregrine Pharmaceuticals
Merck
XenoPort
Aveo Pharmaceuticals
Astellas
Flag link:
AcelRx pain drug shows mixed results in mid-stage trial
AcelRx pain drug shows mixed results in mid-stage trial
Reuters
AcelRx
painkillers
Flag link:
This Week in Biotech
This Week in Biotech
Motley Fool
Pfizer
Novartis
Acadia
Astex
AcelRx
Synergy Pharmaceuticals
Flag link:
4 Healthcare Stock Stories for Tuesday Investment Wellness
4 Healthcare Stock Stories for Tuesday Investment Wellness
Wall Street Cheat Street
JNJ
AcelRx
Herbalife
Santarus
Flag link:
AcelRx post-operative pain treatment meets late-stage study goal
AcelRx post-operative pain treatment meets late-stage study goal
Reuters
post-operative pain
AcelRx
Sufentanil NanoTab PCA System
Flag link: